Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 71034-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 71034-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiamen Lp Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clonidine-01.jpg (Clonidine 01)

Chemical structure of Clonidine Hydrochloride, showing the molecular arrangement including two chlorine atoms and the hydrochloride group.*

FDA Label Image

Clonidine-02.jpg (Clonidine 02)

A line graph showing mean concentration (pg/mL) of clonidine hydrochloride extended-release tablets over time (hours) up to 48 hours. It compares three conditions: fasted state, fed state for clonidine hydrochloride extended-release tablets, and Catapres in the fasted state, illustrating differences in plasma concentration profiles across these conditions.*

FDA Label Image

Clonidine-03.jpg (Clonidine 03)

Label for Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg per tablet, packaged with 60 tablets. The label includes dosage form and strength, manufacturer Xiamen LP Pharmaceutical Co., Ltd., and distributor information. It states the extended-release tablets should be swallowed whole and includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.